J. Oliver

MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

J. Prados, C. Melguizo, R. Ortiz, 2020, Journal of biosciences.

Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells

P. Álvarez, J. Prados, C. Melguizo, 2015, PloS one.

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

P. Álvarez, J. Prados, C. Melguizo, 2014, BMC Cancer.

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

P. Álvarez, J. Prados, C. Melguizo, 2012, Journal of Translational Medicine.

MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

J. Prados, C. Melguizo, R. Ortiz, 2020, Journal of Biosciences.

Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.

P. Álvarez, J. Prados, C. Melguizo, 2013, Recent patents on anti-cancer drug discovery.

Modulation of MGMT and CD 133 Expression in HCT 15 Colon Cancer Cells Exposed To 5-Fluorouracile versus HCT 15 Cancer Stem Cells

C. Jiménez-Luna, G. Perazzoli, L. Cabeza, 2018 .